About Us

Our story

Devon Labs is an innovative company created with the objective of improving the quality of life of patients and their carers, through commercializing our own portfolio of products. We focus on niche markets with the aim of resolving unmet needs and developing a new focus supported by digital technologies that complement conventional treatment.

Time line
2003
Creation of Devon Farmacéutica
2005
Devon Farmacéutica is integrated into ProStrakan
2011
ProStrakan is acquired by Kyowa Kirin
2019
Rebranding of Devon Farmacéutica as Devon Labs
2020
Business operations begin.

Devon Labs’ purpose is to offer value beyond actual medicine, by using tools and digital services that improve patients’ quality of life and optimise the work of their carers and specialists.

Management Team

A team that has worked together for more than ten years, with a proven track record of setting up companies and business units, as well as launching products in diverse therapeutic areas.

Gabriel Pérez Cuevas

Gabriel Pérez Cuevas

CEO

+ See profile
Inmaculada Aibar Sánchez

Inmaculada Aibar Sánchez

CFO

+ See profile
Pedro Acevedo Frías

Pedro Acevedo Frías

Chief Strategy & Commercial Excellence

+ See profile
Ana Fernández Velasco

Ana Fernández Velasco

Chief Medical Officer

+ See profile
Miguel Maroto Centeno

Miguel Maroto Centeno

Chief Commercial Officer

+ See profile